<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sex Hormone Profile Interpretation for Primary Care</title>
    <link rel="stylesheet" href="medical-textbook-styles.css">
</head>
<body>
    <div class="textbook-page">
        <button class="download-btn" onclick="downloadPDF()">
            <svg class="download-icon" fill="currentColor" viewBox="0 0 20 20">
                <path fill-rule="evenodd" d="M3 17a1 1 0 011-1h12a1 1 0 110 2H4a1 1 0 01-1-1zm3.293-7.707a1 1 0 011.414 0L9 10.586V3a1 1 0 112 0v7.586l1.293-1.293a1 1 0 111.414 1.414l-3 3a1 1 0 01-1.414 0l-3-3a1 1 0 010-1.414z" clip-rule="evenodd"></path>
            </svg>
            Download PDF
        </button>

        <div class="page-header">
            <h1>Sex Hormone Profile</h1>
            <div class="subtitle">A Structured Approach to Comprehensive Assessment</div>
        </div>

        <div class="content">
            <!-- Introduction -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üß©</div>
                    <h2>Introduction: Reading the Orchestra, Not Just the Notes</h2>
                </div>
                <p>
                    A standard sex hormone profile typically reports <em>testosterone</em> (or estradiol in many female panels), 
                    <em>prolactin</em>, <em>luteinizing hormone (LH)</em>, <em>follicle-stimulating hormone (FSH)</em>, and 
                    <em>sex hormone‚Äìbinding globulin (SHBG)</em>. Some labs also include calculated free testosterone or a Free Androgen Index (FAI). 
                    To interpret these wisely, think like a conductor: each number is an instrument, but the diagnosis emerges from the harmony (or discord) of the whole ensemble and the tempo set by the hypothalamus and pituitary. 
                    This chapter teaches a <strong>thinking model</strong>‚Äîa practical way to move from numbers to narrative‚Äîso you can hear the physiology behind the panel and make grounded, evidence-based decisions in primary care.
                </p>
                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"Patterns > Points":</strong> The same low testosterone value has different meanings depending on whether LH/FSH are high (primary failure) or low/inappropriately normal (central suppression). Never judge a solo note without the section behind it.</p>
                </div>
            </div>

            <!-- Priority Assessment -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üö®</div>
                    <h2>Priority Assessment</h2>
                </div>
                <p>
                    Before refinement, rule out emergencies and conditions with vision, fertility, or oncologic implications. These patterns should trigger same-day action or urgent referral.
                </p>
                <div class="red-flag-grid">
                    <div class="red-flag-item"><strong>Marked hyperprolactinaemia</strong><br>Very high prolactin with headache/visual change ‚Üí suspect macroadenoma; urgent pituitary imaging and specialist advice.</div>
                    <div class="red-flag-item"><strong>Rapid virilisation</strong><br>New coarse hirsutism, deepening voice, clitoromegaly, or rapidly rising testosterone ‚Üí consider androgen‚Äësecreting tumour.</div>
                    <div class="red-flag-item"><strong>Severe hypogonadism in young adults</strong><br>Very low sex steroids with systemic symptoms (fractures, anaemia, low libido) ‚Üí expedite evaluation to protect bone and fertility.</div>
                    <div class="red-flag-item"><strong>Post‚Äëpartum headache + high prolactin</strong><br>Consider pituitary apoplexy or Sheehan‚Äôs‚Äîurgent specialist input.</div>
                </div>
                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"Check the hook":</strong> If clinical features scream prolactinoma but prolactin is ‚Äònormal/high‚Äënormal‚Äô, ask the lab about high‚Äëdose ‚Äòhook effect‚Äô and request dilutional re‚Äëmeasurement.</p>
                </div>
            </div>

            <!-- Structured History Framework -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üóÇÔ∏è</div>
                    <h2>Structured History Framework</h2>
                </div>
                <p>
                    The history supplies the physiologic context that numbers cannot. Use the prompts below; each question is anchored to a mechanism so you and your patient can co‚Äëreason through the findings.
                </p>
                <div class="two-column">
                    <div>
                        <h4>Symptoms & Timelines</h4>
                        <ul>
                            <li><strong>Libido, erectile function, menstrual regularity:</strong> track hypothalamic‚Äìpituitary‚Äìgonadal (HPG) output over time; chronicity suggests long‚Äëstanding axis change.</li>
                            <li><strong>Hot flushes, night sweats, sleep disruption:</strong> vasomotor instability from low estradiol/testosterone; also consider thyroid and medication effects.</li>
                            <li><strong>Rapid change vs gradual drift:</strong> tumours and iatrogenic causes change quickly; metabolic or functional causes drift.</li>
                            <li><strong>Fertility goals now/later:</strong> alters thresholds for investigation and urgency.</li>
                        </ul>
                    </div>
                    <div>
                        <h4>Exposures & Comorbidities</h4>
                        <ul>
                            <li><strong>Medications:</strong> antipsychotics/antiemetics (‚Üëprolactin), opioids (‚ÜìGnRH), glucocorticoids (central suppression), oral estrogens (‚ÜëSHBG).</li>
                            <li><strong>Metabolic state:</strong> obesity/insulin resistance (‚ÜìSHBG, ‚Üëfree androgens), eating disorders/over‚Äëexercise (hypothalamic amenorrhoea).</li>
                            <li><strong>Sleep apnoea, alcohol, thyroid, liver/renal disease:</strong> common modulators of the axis and of SHBG synthesis.</li>
                            <li><strong>Androgen or estrogen therapy, fertility treatment, anabolic steroids:</strong> interpret all results through the lens of exogenous hormones.</li>
                        </ul>
                    </div>
                </div>
                <div class="highlight-box">
                    <h4>Why We Ask</h4>
                    <p>
                        Each question links to a feedback step: hypothalamus (GnRH pulsatility), pituitary (LH/FSH), gonads (sex steroids), and binding (SHBG). 
                        When symptoms, exposure, and numbers line up, your probability of the correct diagnosis rises sharply.
                    </p>
                </div>
                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"Time‚Äëstamp the sample":</strong> Document clock time, fasting status, and‚Äîif applicable‚Äîcycle day. Testosterone is diurnal; estradiol and gonadotrophins are cyclical. Mis‚Äëtimed tests mislead.</p>
                </div>
            </div>

            <!-- Risk Factor Analysis -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üß≠</div>
                    <h2>Risk Factor Analysis</h2>
                </div>
                <p>Use this visual grid to pre‚Äëtest your hypotheses before ordering repeats or imaging.</p>
                <div class="risk-factors-visual">
                    <div class="risk-factor-item"><strong>Obesity / Insulin resistance</strong><br>‚ÜìSHBG ‚Üí ‚Üëfree androgens; irregular cycles; PCOS phenotype in women; functional central suppression in men.</div>
                    <div class="risk-factor-item"><strong>Oral estrogens / Pregnancy</strong><br>‚ÜëSHBG ‚Üí lower free testosterone despite normal total; confounds screening for deficiency.</div>
                    <div class="risk-factor-item"><strong>Antipsychotics / SSRIs / Metoclopramide</strong><br>‚ÜëProlactin ‚Üí secondary hypogonadism (‚ÜìLH/FSH).</div>
                    <div class="risk-factor-item"><strong>Opioids / Chronic illness / Over‚Äëtraining</strong><br>‚ÜìGnRH drive ‚Üí low/normal LH/FSH with low sex steroids.</div>
                    <div class="risk-factor-item"><strong>Thyroid & liver disease</strong><br>Alter SHBG synthesis; check TFTs and LFTs with puzzling panels.</div>
                    <div class="risk-factor-item"><strong>Androgen or estrogen therapy</strong><br>Axis suppression and binding changes; interpret through drug timing and formulation.</div>
                </div>
                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"SHBG is the lens":</strong> High SHBG makes totals look better than physiology; low SHBG makes them look worse. Adjust your view (free T or FAI) before you act.</p>
                </div>
            </div>

            <!-- Clinical Decision Points -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üîÄ</div>
                    <h2>Clinical Decision Points</h2>
                </div>
                <p>
                    The following flow models translate patterns into actions. Follow the arrows, but let the history steer the speed.
                </p>
                <div class="assessment-flow">
                    <div class="flow-step">
                        <h4>1) Is the sex steroid low (for age/sex) on a correctly timed sample?</h4>
                        <p>If borderline, repeat with proper timing and include SHBG to allow free/bioavailable calculation.</p>
                    </div>
                    <div class="flow-step">
                        <h4>2) What do LH/FSH say?</h4>
                        <p>
                            <strong>High LH/FSH:</strong> primary gonadal failure (testes/ovaries not responding).<br>
                            <strong>Low or inappropriately normal LH/FSH:</strong> central (pituitary/hypothalamic) cause or functional suppression.
                        </p>
                    </div>
                    <div class="flow-step">
                        <h4>3) Where does SHBG point?</h4>
                        <p>High SHBG (oral estrogens, hyperthyroidism, liver disease) can mask low free T; low SHBG (obesity/insulin resistance) inflates free T‚Äîrecalculate.</p>
                    </div>
                    <div class="flow-step">
                        <h4>4) Is prolactin interfering?</h4>
                        <p>Raised prolactin suppresses GnRH ‚Üí low LH/FSH; consider medication causes first, then pituitary imaging if marked/persistent.</p>
                    </div>
                    <div class="flow-step">
                        <h4>5) Align with the story</h4>
                        <p>Do the numbers fit the person? If not, expand the frame (thyroid, cortisol, iron studies, coeliac screen, sleep apnoea, metabolic risk).</p>
                    </div>
                </div>

                <div class="interpretation-grid">
                    <div class="interpretation-item">
                        <h4>Low Testosterone + <span title="High LH/FSH">‚ÜëLH/FSH</span></h4>
                        <p>Primary testicular failure (e.g., Klinefelter, post‚Äëorchitis/chemo/radiation). Assess fertility, bone, and cardiometabolic risks; refer as appropriate.</p>
                    </div>
                    <div class="interpretation-item">
                        <h4>Low Testosterone + <span title="Low/normal LH/FSH">‚ÜòLH/FSH</span></h4>
                        <p>Secondary hypogonadism (pituitary/hypothalamic, functional suppression from illness/opioids/obesity). Screen meds, prolactin, pituitary symptoms.</p>
                    </div>
                    <div class="interpretation-item">
                        <h4>Elevated Prolactin + Low/Normal LH/FSH</h4>
                        <p>Hyperprolactinaemia with gonadotrophin suppression. Check drugs, pregnancy, hypothyroidism; if marked/persistent, discuss imaging and endocrine referral.</p>
                    </div>
                    <div class="interpretation-item">
                        <h4>Women: High Androgens + Low SHBG</h4>
                        <p>Insulin resistance and PCOS phenotype likely; address metabolic drivers and cycle control; exclude late‚Äëonset CAH if features suggest.</p>
                    </div>
                    <div class="interpretation-item">
                        <h4>Women: Low Estradiol + High FSH</h4>
                        <p>Primary ovarian insufficiency‚Äîdiscuss fertility impact, bone protection, and indications for HRT.</p>
                    </div>
                    <div class="interpretation-item">
                        <h4>Women: Oligo‚ÄëAmenorrhoea + Normal Androgens</h4>
                        <p>Consider functional hypothalamic amenorrhoea (energy deficit, stress); counsel on nutrition, training load, and bone health.</p>
                    </div>
                </div>

                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"Follow the feedback loop":</strong> Pair each sex steroid with its pituitary driver. Discordance localises the fault and prevents reflex prescribing.</p>
                </div>
            </div>

            <!-- Treatment History Insights -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üíä</div>
                    <h2>Treatment History Insights</h2>
                </div>
                <p>
                    Therapy reshapes physiology. Document <em>what</em> (agent and route), <em>when</em> (timing to blood draw), and <em>why</em> (indication and goals), then interpret through that prism.
                </p>
                <div class="parameter-grid">
                    <div class="parameter-card normal">
                        <h4>Exogenous Testosterone (men)</h4>
                        <p>Expect suppressed LH/FSH. Judge adequacy using symptoms + trough levels (timed to formulation). Persisting low values ‚Üí adherence, absorption, or SHBG issues.</p>
                    </div>
                    <div class="parameter-card abnormal-high">
                        <h4>Combined Oral Contraceptive / Oral Estrogen</h4>
                        <p>Raises SHBG ‚Üí lowers free T despite normal total; androgen measures off therapy are more informative when assessing hyperandrogenism.</p>
                    </div>
                    <div class="parameter-card abnormal-low">
                        <h4>Dopamine Agonists (hyperprolactinaemia)</h4>
                        <p>Prolactin should fall; restoration of gonadal function is the clinical target. If prolactin normalises but symptoms persist, re‚Äëexamine other axes.</p>
                    </div>
                    <div class="parameter-card critical">
                        <h4>Antipsychotics / Metoclopramide</h4>
                        <p>Can elevate prolactin substantially; collaborate with prescriber on risk‚Äìbenefit and alternatives if hypogonadal symptoms are significant.</p>
                    </div>
                </div>
                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"Trend beats snapshot":</strong> After starting, stopping, or changing therapy, compare against the patient‚Äôs personal baseline and goals; one off‚Äëtarget value rarely mandates a major pivot.</p>
                </div>
            </div>

            <!-- Summary -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üìà</div>
                    <h2>Summary: The Thinking Model on One Page</h2>
                </div>
                <div class="highlight-box">
                    <h4>Five Moves to Master</h4>
                    <ol>
                        <li><strong>Time it right:</strong> record time, fasting, and (if relevant) cycle day; repeat borderline values.</li>
                        <li><strong>Read the duet:</strong> interpret sex steroid alongside LH/FSH to localise primary vs central.</li>
                        <li><strong>Adjust the lens:</strong> use SHBG to judge free/bioavailable hormone before labelling deficiency.</li>
                        <li><strong>Unmask prolactin:</strong> check drugs, pregnancy, thyroid; pursue imaging if marked/persistent.</li>
                        <li><strong>Match the story:</strong> align with symptoms, meds, and goals; manage risks (bone, cardiometabolic, fertility).</li>
                    </ol>
                </div>
                <div class="two-column">
                    <div>
                        <h4>Clinical Scenarios You‚Äôll See Weekly</h4>
                        <ul>
                            <li>Male fatigue + low morning T with ‚ÜëLH/FSH ‚Üí primary testicular failure; discuss fertility and bone.
                            </li>
                            <li>Male obesity + borderline T + low SHBG ‚Üí free T near‚Äënormal; prioritise weight, sleep, and metabolic care before long‚Äëterm TRT.
                            </li>
                            <li>Female hirsutism + irregular cycles + low SHBG ‚Üí insulin resistance/PCOS phenotype; holistic metabolic strategy with cycle control.
                            </li>
                            <li>Female amenorrhoea after weight loss + low/normal LH/FSH ‚Üí functional hypothalamic amenorrhoea; nutrition/restoration before hormones.
                            </li>
                        </ul>
                    </div>
                    <div>
                        <h4>Decision Guard‚ÄëRails</h4>
                        <ul>
                            <li>Confirm abnormalities twice (same lab, proper timing) before diagnosing chronic deficiency.</li>
                            <li>Don‚Äôt treat a number‚Äîtreat a person with symptoms, risks, and goals.</li>
                            <li>Think bones, mood, metabolic health, and fertility at each review.</li>
                        </ul>
                    </div>
                </div>
                <div class="clinical-pearl">
                    <h3>Clinical Pearl</h3>
                    <p><strong>"When the pattern is weird, widen the frame":</strong> Add thyroid/liver tests, iron studies, coeliac screen, and sleep assessment. Hormones rarely misbehave alone.</p>
                </div>
            </div>

            <!-- Clinical Pearls Recap (ensuring 5‚Äì7 total) -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">üí°</div>
                    <h2>Clinical Pearls Recap</h2>
                </div>
                <div class="clinical-pearl"><h3>Clinical Pearl</h3><p><strong>"Patterns > Points"</strong>: interpret in clusters, not single values.</p></div>
                <div class="clinical-pearl"><h3>Clinical Pearl</h3><p><strong>"Check the hook"</strong>: beware assay hook effect in very high prolactin.</p></div>
                <div class="clinical-pearl"><h3>Clinical Pearl</h3><p><strong>"Time‚Äëstamp the sample"</strong>: diurnal and cyclical biology matter to meaning.</p></div>
                <div class="clinical-pearl"><h3>Clinical Pearl</h3><p><strong>"SHBG is the lens"</strong>: totals can deceive without bioavailable context.</p></div>
                <div class="clinical-pearl"><h3>Clinical Pearl</h3><p><strong>"Follow the feedback loop"</strong>: pair sex steroids with LH/FSH to localise pathology.</p></div>
                <div class="clinical-pearl"><h3>Clinical Pearl</h3><p><strong>"Trend beats snapshot"</strong>: compare to the person‚Äôs baseline and goals over time.</p></div>
            </div>

            <!-- References Section (end) -->
            <div class="references-section">
                <h3>üîó Clinical Guidelines & Evidence Base</h3>
                <div class="guideline-grid">
                    <div class="guideline-item">
                        <strong>NICE Guideline NG23</strong><br>
                        <em>Menopause: identification and management</em> ‚Äì 2024 update<br>
                        <a href="https://www.nice.org.uk/guidance/ng23">Access Guidelines</a>
                    </div>
                    <div class="guideline-item">
                        <strong>NICE CKS</strong><br>
                        <em>Polycystic ovary syndrome: assessment & management</em> ‚Äì current<br>
                        <a href="https://cks.nice.org.uk/topics/polycystic-ovary-syndrome/management/management-adults/">Access Guidelines</a>
                    </div>
                    <div class="guideline-item">
                        <strong>Endocrine Society</strong><br>
                        <em>Testosterone Therapy in Men with Hypogonadism</em> ‚Äì Clinical Practice Guideline<br>
                        <a href="https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy">Access Guideline</a>
                    </div>
                    <div class="guideline-item">
                        <strong>Society for Endocrinology (UK)</strong><br>
                        <em>Guidelines for Testosterone Replacement in Male Hypogonadism</em> ‚Äì 2022/23<br>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34811785/">Access Summary</a>
                    </div>
                    <div class="guideline-item">
                        <strong>Nature Rev Endocrinol</strong><br>
                        <em>Diagnosis & Management of Prolactin‚Äësecreting Pituitary Tumours</em> ‚Äì 2023 review<br>
                        <a href="https://www.nature.com/articles/s41574-023-00886-5">Access Review</a>
                    </div>
                    <div class="guideline-item">
                        <strong>NHS Laboratory Guidance</strong><br>
                        <em>SHBG interpretation in practice</em> ‚Äì 2024
                        <br><a href="https://www.gloshospitals.nhs.uk/our-services/services-we-offer/pathology/tests-and-investigations/sex-hormone-binding-globulin-shbg/">Access Resource</a>
                    </div>
                </div>
            </div>

            <!-- Quality Checklist -->
            <div class="section">
                <div class="section-header">
                    <div class="section-icon">‚úÖ</div>
                    <h2>Quality Checklist</h2>
                </div>
                <ul>
                    <li>Uses external CSS/JS only (no inline styles/scripts)</li>
                    <li>Follows the exact HTML class structure</li>
                    <li>Integrates current NICE/Endocrine guidance naturally</li>
                    <li>Includes 6 clinical pearls with memorable titles</li>
                    <li>Uses visual elements: <code>.red-flag-grid</code>, <code>.risk-factors-visual</code>, <code>.assessment-flow</code>, <code>.interpretation-grid</code>, <code>.parameter-grid</code></li>
                    <li>Explains <em>why</em> we ask questions, not just <em>what</em> to ask</li>
                    <li>Designed to print as ~3 pages with optimised CSS</li>
                    <li>Download button wired to <code>downloadPDF()</code></li>
                </ul>
            </div>
        </div>
    </div>

    <script src="medical-textbook-scripts.js"></script>
</body>
</html>
